食道カンジダ症
WordNet
- an infection caused by fungi of the genus Monilia or Candida (especially Candida albicans) (同)moniliasis, monilia disease
- relating to the esophagus
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/06/12 15:25:24」(JST)
[Wiki en表示]
Esophageal candidiasis |
Endoscopic image of esophageal candidiasis in a patient after chemotherapy. Brushings confirmed the presence of hyphae
|
Classification and external resources |
ICD-9-CM |
112.84 |
[edit on Wikidata]
|
Esophageal candidiasis is an opportunistic infection of the esophagus by Candida albicans. The disease usually occurs in patients in immunocompromised states, including post-chemotherapy and in AIDS. However, it can also occur in patients with no predisposing risk factors, and is more likely to be asymptomatic in those patients.[1] It is also known as candidal esophagitis or monilial esophagitis.
Contents
- 1 Clinical presentation
- 2 Diagnosis
- 3 Therapy
- 4 References
Clinical presentation
Patients with esophageal candidiasis present with odynophagia, or painful swallowing. Longstanding esophageal candidiasis can result in weight loss. There is often concomittant thrush.
Some patients present with esophageal candidiasis as a first presentation of systemic candidiasis.
Diagnosis
In most cases the diagnosis is established based on response to therapy. Patients in whom esophageal candidiasis is suspected should receive a brief course of antifungal therapy with fluconazole. If the infection resolves after treatment with fluconazole, then the diagnosis of esophageal candidiasis is made and no further investigation is needed. However, if the infection persists or if there are other factors involved which may warrant further investigation, then patient will undergo an esophagogastroduodenoscopy if it is safe to do so. Endoscopy often reveals classic diffuse raised plaques that characteristically can be removed from the mucosa by the endsocope. Brushing or biopsy of the plaques shows yeast and pseudohyphae by histology that are characteristic of Candida species.
-
-
-
A severe case of candidiasis
-
H&E stain of esophagus showing Candida hyphae within the lamina propria
Therapy
The current first-line treatment is fluconazole, 200 mg. on the first day, followed by daily dosing of 100 mg. for at least 21 days total. Treatment should continue for 14 days after relief of symptoms. [Note: this page previously listed first-line treatment using a single dose of fluconazole (750 mg), but that is actually treatment for oropharyngeal, not esophageal Candidiasis.[2]] Other therapy options include:
- nystatin
- other oral triazoles, such as itraconazole
- caspofungin, used in refractory or systemic cases
- amphotericin, used in refractory or systemic cases
References
- ^ Mimidis, K; Papadopoulos, V; Margaritis, V; Thomopoulos, K; Gatopoulou, A; Nikolopoulou, V; Kartalis, G (February 2005). "Predisposing factors and clinical symptoms in HIV-negative patients with Candida oesophagitis: are they always present?". International journal of clinical practice 59 (2): 210–3. doi:10.1111/j.1742-1241.2004.00249.x. PMID 15854199.
- ^ Hamza OJ, Matee MI, Brüggemann RJ, et al. (2008). "Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: A randomized, double-blind, double-dummy trial". Clin Infect Dis 47 (10): 1270–1276. doi:10.1086/592578. PMID 18840077.
Fungal infection and mesomycetozoea (B35–B49, 110–118)
|
|
Superficial and
cutaneous
(dermatomycosis):
Tinea = skin;
Piedra (exothrix/
endothrix) = hair |
Ascomycota |
Dermatophyte
(Dermatophytosis) |
By location |
- Tinea barbae/tinea capitis
- Tinea corporis
- Tinea cruris
- Tinea manuum
- Tinea pedis (athlete's foot)
- Tinea unguium/onychomycosis
- White superficial onychomycosis
- Distal subungual onychomycosis
- Proximal subungual onychomycosis
- Tinea corporis gladiatorum
- Tinea faciei
- Tinea imbricata
- Tinea incognito
- Favus
|
|
By organism |
- Epidermophyton floccosum
- Microsporum canis
- Microsporum audouinii
- Trichophyton interdigitale/mentagrophytes
- Trichophyton tonsurans
- Trichophyton schoenleini
- Trichophyton rubrum
- Trichophyton verrucosum
|
|
|
Other |
- Hortaea werneckii
- Piedraia hortae
|
|
|
Basidiomycota |
- Malassezia furfur
- Tinea versicolor
- Pityrosporum folliculitis
- Trichosporon
|
|
|
Subcutaneous,
systemic,
and opportunistic |
Ascomycota |
Dimorphic
(yeast+mold) |
Onygenales |
- Coccidioides immitis/Coccidioides posadasii
- Coccidioidomycosis
- Disseminated coccidioidomycosis
- Primary cutaneous coccidioidomycosis. Primary pulmonary coccidioidomycosis
- Histoplasma capsulatum
- Histoplasmosis
- Primary cutaneous histoplasmosis
- Primary pulmonary histoplasmosis
- Progressive disseminated histoplasmosis
- Histoplasma duboisii
- Lacazia loboi
- Paracoccidioides brasiliensis
|
|
Other |
- Blastomyces dermatitidis
- Blastomycosis
- North American blastomycosis
- South American blastomycosis
- Sporothrix schenckii
- Penicillium marneffei
|
|
|
Yeast-like |
- Candida albicans
- Candidiasis
- Oral
- Esophageal
- Vulvovaginal
- Chronic mucocutaneous
- Antibiotic candidiasis
- Candidal intertrigo
- Candidal onychomycosis
- Candidal paronychia
- Candidid
- Diaper candidiasis
- Congenital cutaneous candidiasis
- Perianal candidiasis
- Systemic candidiasis
- Erosio interdigitalis blastomycetica
- C. glabrata
- C. tropicalis
- C. lusitaniae
- Pneumocystis jirovecii
- Pneumocystosis
- Pneumocystis pneumonia
|
|
Mold-like |
- Aspergillus
- Aspergillosis
- Aspergilloma
- Allergic bronchopulmonary aspergillosis
- Primary cutaneous aspergillosis
- Exophiala jeanselmei
- Fonsecaea pedrosoi/Fonsecaea compacta/Phialophora verrucosa
- Geotrichum candidum
- Pseudallescheria boydii
|
|
|
Basidiomycota |
- Cryptococcus neoformans
- Cryptococcosis
- Trichosporon spp
- Trichosporonosis
|
|
Zygomycota
(Zygomycosis) |
Mucorales
(Mucormycosis) |
- Rhizopus oryzae
- Mucor indicus
- Lichtheimia corymbifera
- Syncephalastrum racemosum
- Apophysomyces variabilis
|
|
Entomophthorales
(Entomophthoramycosis) |
- Basidiobolus ranarum
- Conidiobolus coronatus/Conidiobolus incongruus
|
|
|
Microsporidia
(Microsporidiosis) |
- Enterocytozoon bieneusi/Encephalitozoon intestinalis
|
|
|
Mesomycetozoea |
|
|
Ungrouped |
- Alternariosis
- Fungal folliculitis
- Fusarium
- Granuloma gluteale infantum
- Hyalohyphomycosis
- Otomycosis
- Phaeohyphomycosis
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization.
- Andes DR, Reynolds DK, Van Wart SA, Lepak AJ, Kovanda LL, Bhavnani SM.Source1685 Highland Ave, Department of Medicine, University of Wisconsin, Madison, WI 53711.
- Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2013 Aug 19. [Epub ahead of print]
- Echinocandins exhibit concentration dependent effects against Candida species and preclinical studies support large, infrequent dosing. The current study examines the pharmacokinetics/pharmacodynamics of two multicenter, randomized trials of micafungin dosing regimens that varied in both dose level
- PMID 23959319
- Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials.
- Ford AC, Peyrin-Biroulet L.Source1] Leeds Gastroenterology Institute, Leeds General Infirmary, Leeds, UK [2] Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.
- The American journal of gastroenterology.Am J Gastroenterol.2013 Aug;108(8):1268-76. doi: 10.1038/ajg.2013.138. Epub 2013 May 7.
- OBJECTIVES: Several anti-tumor necrosis factor-α (TNFα) antibodies have demonstrated efficacy in Crohn's disease (CD) and ulcerative colitis (UC). These drugs carry the theoretical risk of opportunistic infection, but no systematic review and meta-analysis has examined this issue specifically.METH
- PMID 23649185
- Relationship between clinical factors and severity of esophageal candidiasis according to Kodsi's classification.
- Asayama N, Nagata N, Shimbo T, Nishimura S, Igari T, Akiyama J, Ohmagari N, Hamada Y, Nishijima T, Yazaki H, Teruya K, Oka S, Uemura N.SourceDepartment of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Tokyo, Japan.
- Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E.Dis Esophagus.2013 Jul 4. doi: 10.1111/dote.12102. [Epub ahead of print]
- Severe Candida esophagitis (CE) may lead to development of strictures, hemorrhage, esophagotracheal fistula, and a consequent decrease in quality of life. Although the severity of CE has been classified based on macroscopic findings on endoscopy, the clinical significance remains unknown. The aim of
- PMID 23826847
Japanese Journal
- アルゴンプラズマ凝固療法が奏功した難治性食道カンジダ症の1例
- 留置 辰治,松中 秀之,西川 泉,井畑 裕三子,田伏 弘行,森 良幸,篠永 卓郎,東 克彦,岡 政志,一瀬 雅夫
- 日本消化器内視鏡学会雑誌 = Gastroenterological endoscopy 52(4), 1250-1256, 2010-04-20
- 症例は74歳,男性.平成10年に下部食道に厚い白苔を伴う食道カンジダ症を認め,数年にわたり種々の抗真菌剤を繰り返し投与されたが白苔は残存したままであった.平成18年2月に食物の通過障害がひどくなり,内視鏡検査で咽頭部より食道胃粘膜接合部に広がるカンジダ病変を認め,特に下部食道は以前と同様に厚い白苔に覆われていた.抗真菌剤の投与とアルゴンプラズマ凝固療法(APC)を併用することで白苔は消失した.各種 …
- NAID 10026910002
- Isolation of Candida Species is an Important Clue for Suspecting Gastrointestinal Tract Perforation as a Cause of Empyema
- Ishiguro Takashi,Takayanagi Noboru,Ikeya Tomohiko,Yoshioka Hiroaki,Yanagisawa Tsutomu,Hoshi Eishin,Hoshi Toshiko,Sugita Yutaka,Kawabata Yoshinori
- Internal Medicine 49(18), 1957-1964, 2010
- … Primary diseases of these 5 patients were spontaneous esophageal rupture in 3 patients, esophageal rupture due to lung cancer invasion in 1 patient, and gastric ulcer perforation in 1 patient. … None of these 5 patients had esophageal candidiasis. …
- NAID 130000336883
- 睡眠前の点鼻ステロイド剤長期投与が原因と思われた食道カンジダ症の1例
- 周東 寛,野口 久,西片 光,滝沢 健司,周東 千鶴,永田 眞,寺師 義典,山口 道也,滝沢 敬夫,渡辺 建介,登坂 薫,岡野 昌彦,小泉 昭
- アレルギー 56(7), 714-720, 2007-07-30
- 吸入ステロイドの副作用の一つとして,口腔・食道カンジダ症の報告がある.点鼻ステロイド長期投与により出現した「嚥下による口腔・食道通過時に不快感」の症状を呈した症例に口腔・食道カンジダ症を発見した.そして点鼻ステロイドを中止したことにより著明に改善した症例を経験したので報告する.症例は69歳女性.嚥下時上胸部に通過障害の違和感を主訴にて来院した.数年前より通年性アレルギー性鼻炎と診断され, 2年前よ …
- NAID 110006367818
Related Links
- esophageal candidiasis Candida esophagitis Infectious disease Inflammation by Candida spp Risk factors Immunocompromise–eg, AIDS, heart, kidney, other ... Approved in 2005 for the treatment of patients with esophageal ...
- CATIE fact sheet - Esophageal candidiasis, 1 of 2 fact sheet Esophageal Candidiasis Winter 2001 Summary: Esophageal candidiasis is a fungal infection of the esophagus — the tube connecting the mouth to the stomach. There are ...
Related Pictures
★リンクテーブル★
[★]
- 英
- esophageal candidiasis
- 関
- 食道炎
概念
- 正常人の約半数に口腔内や胃内にカンジダが存在するが、何らかの原因により食道粘膜を主座にカンジダが増殖した疾患。
- 全身の重症疾患や抗生剤、ステロイド剤、抗癌薬などの使用例、胃切除例など全身的免疫機構(特に細胞性免疫)低下時に発症頻度が増す。
原因
- 悪性腫瘍、膠原病、AIDS、糖尿病、腎不全、肝硬変、高用量ステロイドの長期投与、広域抗菌薬長期投与
- 食道炎
- 食物・異物の停留にともなう機械的な食道粘膜傷害
- 吸入ステロイド
- プロトンポンプ阻害薬
症状
軽症例ではほとんどが無症状時
身体所見
検査
- 上部消化管内視鏡:数mm前後で光沢のない小隆起性の白色付着物(白苔)がびまん性、縦列状に存在。白苔は水洗しでも落ちにくい。重症例では白苔が増大癒合し、縦列融合や地図状白苔を形成する。
- 培養検査:サブロー培地(Sabouraud培地)で培養。検鏡ではHE染色、PAS染色、グラム染色にて菌体を同定する。
鑑別診断
治療
- 以前はアムホテリシンBの投与が行われていたが、抗真菌薬のゼリー剤で治療できるようになってきている。
[★]
- 関
- esophagus、oesophageal、oesophagus
[★]
- (pl.)candidiase